0001613386-20-000001.txt : 20200814
0001613386-20-000001.hdr.sgml : 20200814
20200814105734
ACCESSION NUMBER: 0001613386-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200814
DATE AS OF CHANGE: 20200814
EFFECTIVENESS DATE: 20200814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aminex Therapeutics, Inc.
CENTRAL INDEX KEY: 0001613386
IRS NUMBER: 263969765
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-373242
FILM NUMBER: 201102544
BUSINESS ADDRESS:
STREET 1: 11335 NE 122ND
STREET 2: SUITE 105
CITY: KIRKLAND
STATE: WA
ZIP: 98034
BUSINESS PHONE: 425-286-4222
MAIL ADDRESS:
STREET 1: 11335 NE 122ND
STREET 2: SUITE 105
CITY: KIRKLAND
STATE: WA
ZIP: 98034
D
1
primary_doc.xml
X0708
D
LIVE
0001613386
Aminex Therapeutics, Inc.
6947 Coal Creek Parkway SE
Suite 364
Newcastle
WA
WASHINGTON
98059
512-413-8255
WASHINGTON
None
None
Corporation
true
James
Skaggs
6947 Coal Creek Parkway SE
Suite 364
Newcastle
WA
WASHINGTON
98059
Executive Officer
Director
Mark
Burns
6947 Coal Creek Parkway SE
Suite 364
Newcastle
WA
WASHINGTON
98059
Executive Officer
Director
Jeff
Miller
6947 Coal Creek Parkway SE
Suite 364
Newcastle
WA
WASHINGTON
98059
Director
Rhonda
Rhyne
6947 Coal Creek Parkway SE
Suite 364
Newcastle
WA
WASHINGTON
98059
Director
Stacy
Hock
6947 Coal Creek Parkway SE
Suite 364
Newcastle
WA
WASHINGTON
98059
Director
Roger
Ulrich
6947 Coal Creek Parkway SE
Suite 364
Newcastle
WA
WASHINGTON
98059
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-07-31
false
true
false
0
3000000
2865125
134875
false
96
0
0
0
false
Aminex Therapeutics, Inc.
/s/ James B. Skaggs
James B. Skaggs
Chief Executive Officer
2020-08-13